eculizumab monoclonal antibody drug. targets complement component 5 and indications for use include paroxysmal nocturnal

ahus antibody atypical biological biosimilar biotech biotechnology c5 cascade complement component disease drug eculizumab excessive expensive hemoglobinuria hemolytic immunoglobulin immunology infusion inhibitor injection inn mab monoclonal nocturnal nomenclature orphan paroxysmal peptide pnh price protein syndrome terminal uremic